Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely administered as a vaccine for tuberculosis. BCG is also used as a biotherapy for superficial bladder carcinoma.

From review of the currently available trial evidence, several clinical recommendations for bladder tumor management ... of patients with CIS to receive BCG and eMCC. One group was randomly ...

The treatment consists of instilling the BCG vaccine directly into the bladder. When the treatment works, the 15-year ...

The California biotech said it had not been ... There are few treatment options for patients who develop BCG-unresponsive bladder cancer, which raises the risk of the cancer spreading throughout ...

Regulatory compliance: The study is designed in compliance with the FDA’s guidance for BCG-Unresponsive NMIBC, highlighting ...